GlassScriptPhysician profile
Babak Sarani
NPI 1942246814
$72,613.51
in general payments reported to CMS, 2019-2025
16 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $1,315 · 2021: $11K · 2022: $16K · 2023: $13K · 2024: $17K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,550 · Consulting Fee: $4,094 · Food and Beverage: $1,715 · Honoraria: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,682.00 |
| Travel and Lodging | $13,195.10 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,550.00 |
| Consulting Fee | $4,094.25 |
| Food and Beverage | $1,715.34 |
| Honoraria | $433.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $24,488.72 | 2019-2025 | Ribloc, Biobridge, Acutie II |
| Haemonetics Corporation | $21,348.72 | 2021-2025 | Teg6s Hemostasis System, Teg5000 Hemostasis Analyzer, Teg Manager |
| Medtronic, INC. | $11,535.32 | 2021-2025 | Nellcor, Invos |
| Intuitive Surgical, INC. | $5,261.58 | 2022-2025 | Da Vinci Surgical System |
| Csl Behring | $4,229.65 | 2022-2024 | |
| Belmont Instrument LLC | $1,969.25 | 2021-2024 | |
| Rti Surgical, INC | $1,440.00 | 2021 | |
| Kci USA, INC. | $609.24 | 2019-2020 | |
| Prytime Medical Devices, INC. | $554.30 | 2022-2023 | Er-Reboa Plus |
| Curvafix, INC. | $433.13 | 2024 | Curvafix Im Implant |
| Portola Pharmaceuticals, LLC | $365.40 | 2019 | |
| Zimmer Biomet Holdings, INC. | $145.82 | 2024 | Advantagerib |
| Baxter Healthcare | $139.13 | 2023 | Floseal |
| Astrazeneca Pharmaceuticals LP | $55.22 | 2022 | |
| Edwards Lifesciences Corporation | $38.03 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Sarani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.